We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

92 hedge funds and large institutions have $296M invested in Lumos Pharma, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more call options, than puts

Call options by funds: $33.7M | Put options by funds: $19.4M

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

35% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 26

5% more funds holding

Funds holding: 88 → 92 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less capital invested

Capital invested by funds: $353M → $296M (-$57.7M)

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
35
Reduced
26
Closed
8
Calls
$33.7M
Puts
$19.4M
Net Calls
+$14.3M
Net Calls Change
-$3.54M

Top Buyers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
+$7.94M
2
HT
HAP Trading
New York
+$5.09M
3
DFO
Duquesne Family Office
New York
+$4.46M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.54M
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$3.71M
2
ST
Spot Trading
Illinois
-$3.58M
3
JG
Jefferies Group
New York
-$1.82M
4
IHM
Iguana Healthcare Management
New York
-$1.33M
5
BCM
Bluefin Capital Management
New York
-$1.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.6M -$21.3K -97 -1%
CWG
27
C WorldWide Group
Denmark
$1.41M +$1.54M +7,000 New
DCM
28
Driehaus Capital Management
Illinois
$1.4M -$324K -1,472 -17%
Principal Financial Group
29
Principal Financial Group
Iowa
$1.35M -$12.1K -55 -0.8%
BIM
30
BlackRock Investment Management
Delaware
$1.24M +$10.8K +49 +0.8%
ERSOT
31
Employees Retirement System of Texas
Texas
$964K -$415K -1,889 -27%
Charles Schwab
32
Charles Schwab
California
$947K +$22.4K +102 +2%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$914K -$78K -355 -7%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$822K -$268K -1,217 -22%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$783K +$9.89K +45 +1%
AllianceBernstein
36
AllianceBernstein
Tennessee
$709K – – –
Group One Trading
37
Group One Trading
Illinois
$682K +$111K +504 +17%
Millennium Management
38
Millennium Management
New York
$660K -$606K -2,758 -45%
RCM
39
RA Capital Management
Massachusetts
$643K +$733K +3,333 New
ZIM
40
Zacks Investment Management
Illinois
$630K +$56.5K +257 +9%
AQR Capital Management
41
AQR Capital Management
Connecticut
$628K -$269K -1,222 -27%
TA
42
Teachers Advisors
New York
$595K – – –
BSW
43
Buckingham Strategic Wealth
Missouri
$568K – – –
PFS
44
Prospera Financial Services
Texas
$557K – – –
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$493K – – –
ProShare Advisors
46
ProShare Advisors
Maryland
$477K -$106K -481 -16%
Swiss National Bank
47
Swiss National Bank
Switzerland
$463K +$19.6K +89 +4%
CCM
48
Coe Capital Management
Illinois
$428K +$489K +2,222 New
PAM
49
Paradigm Asset Management
New York
$411K -$44K -200 -9%
RJA
50
Raymond James & Associates
Florida
$363K +$69K +314 +20%
1
2
3 4

LUMO Hedge Fund Activity: Q3 2014 in Review

92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q3 2014, worth a combined $296M — down 16% from $353M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LUMO positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 26 trimmed.

The largest buyer was PointState Capital, adding an estimated $7.94M. The largest seller was Franklin Resources, cutting an estimated $3.71M.

  • 92 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q3 2014, up from 88 in Q2 2014.
  • Funds reported $296M of Lumos Pharma, Inc. Common Stock stock for Q3 2014, down 16% quarter-over-quarter.
  • 13 funds opened new Lumos Pharma, Inc. Common Stock positions in Q3 2014 and 8 closed out, a net change of +5 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q3 2014 was PointState Capital, an estimated $7.94M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q3 2014 was Franklin Resources, an estimated $3.71M sold.

Based on aggregated 13F filings for Q3 2014.